MYM Nutraceuticals closes $2.85M first tranche of private placement

News Release

MYM Announces Closing of First Tranche of Non-Brokered Financing

Vancouver, B.C., October 23, 2017 – MYM Nutraceuticals Inc., (CSE: MYM) (the “Company” or “MYM”) is pleased to announce it has closed the first tranche of its non-brokered private placement of 5,709,000 units at a price of $0.50 per unit for gross proceeds of $2,854,500.

Each unit in the private placement is comprised of one common share and one transferable share purchase warrant with each warrant exercisable into one additional common share at a price of $1.00 for a period of one year. The securities will be subject to a four month and one day hold period under securities laws.

Finder’s fees totalling $102,570.83 were paid on the financing.

Insiders purchased 566,250 units in the first tranche of the private placement.

The Company intends to use the net proceeds from the private placement for general work-ing capital and corporate purposes.

About MYM

MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada li-censes to produce and sell high-end organic medicinal cannabis supplements and topical products. To ensure a strong presence and growth potential within the industry, MYM is ac-tively looking to acquire complementary businesses and assets in the technology, nutraceu-ticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the follow-ing symbols: (CSE: MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

Rob Gietl, CEO MYM Nutraceuticals Inc.